CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Candel Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.21+0.02 (+0.24%)
Close on Oct 19, 2026
- Market cap
- $608.62M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Candel Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 6, 2026 | Sep 10, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 23, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2025 | Dec 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 21, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 22, 2025 | May 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2025 | Apr 23, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 11, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |